Sartorius keeps dividend for 2009 unchanged
Published in
M2 Pharma
on Tuesday, 09 March 2010 at
08:39 GMT
Copyright (C) 2010, M2 Communications
9 March 2010 - German laboratory and process equipment provider Sartorius AG (ETR: SRT) said on Monday it proposed a dividend of EUR0.42 per preference share and EUR0.40 per ordinary share for 2009, unchanged from 2008.
In February, the company posted a 14.2% year-on-year increase in its adjusted net profit to EUR20.8m (USD28.3m) for 2009.
(EUR1 = USD1.362)
Release date: 09 Mar 2010
Other Latest Headlines
·ImmunoGen gets orphan drug designation for IMGN901 compound (09 Mar 2010 12:22pm)
·Lilly to acquire European rights to Pfizer Animal Health assets (09 Mar 2010 12:16pm)
·Biotie, Pfizer to end PDE10 discovery phase in June '10 (09 Mar 2010 12:11pm)
·Actavis sells Bulgarian distributor (09 Mar 2010 8:23am)
·Lilly to acquire European rights to Pfizer Animal Health assets (09 Mar 2010 12:16pm)
·Biotie, Pfizer to end PDE10 discovery phase in June '10 (09 Mar 2010 12:11pm)
·Actavis sells Bulgarian distributor (09 Mar 2010 8:23am)
